Forty51 Ventures’ $43 Million Fundraising

VISCHER and Dechert advised Forty51 Ventures on the deal.FORTY51 Ventures, a Biotech venture capital firm, closed its first fund, FORTY51 Ventures Fund I SCSp, FIAR, which…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here